Kamada Ltd
KMDA
Closed
$8.24
Closed
-(-)
At close
Get professional financial guidance
Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply
About
Kamada Ltd. is a biopharmaceutical company, which focuses on specialty plasma-derived therapeutic. The company is headquartered in Rehovot, Central(Hamerkaz) and currently employs 393 full-time employees. The company went IPO on 2005-08-01. The firm uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purified, liquid form, as well as other plasma-derived Immune globulins.
Key stats
Open
$8.00
Volume
112.88K
Market cap
$475.40M
Prev. close
$8.24
Impl / hst vl
-
Open interest
$0.00
$8.00
Day’s Range
$8.25
$6.85
52W Range
$9.35
Valuation
44
Valuation score
Fairly Valued
P/E
20.65
P/S
2.31
P/B
1.62
Current ratio
-
Debt / Equity
-
ROE
-
Gross margin
-
Income growth
124.15%
FCF growth
-1,362.74
Apr
7
Dividends
The last payment date was Apr 7, 2026
Div. per Share
$0.25
Div. Yield
3.03%
Payout Ratio
-
Div. Growth YoY
25.00%
Analysts estimates
Consensus rating
Buy
The average rating from top 5 analysts indicates that stock is expected to perform in line with the market
Str. Sell
Sell
Hold
Buy
Str. Buy
Avg. price target
$13.26
The top 6 analysts forecasts that 12-month price may increase by 60.92%, with a low of $11.11 and a high of $15.75
$11.11
Low
$13.26
Avg
$15.75
High
Current price
Earnings
Q2 ‘26 revenue
$54.92M
Q2 ‘26 net income
$9.26M
Revenue
Net income
Previous EPS
$0.07
Estimate EPS
$0.11
Actual EPS
Estimate EPS
Explore the Healthcare sector
Get professional financial guidance
Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply